期刊
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 77, 期 1, 页码 155-163出版社
OXFORD UNIV PRESS
DOI: 10.1093/jac/dkab378
关键词
-
资金
- IAME
- Fondation pour la Recherche Medicale [DEQ20161136698]
Combining colistin and fosfomycin shows synergistic and bactericidal effects against NDM-1-producing E. coli, reducing mortality and bacterial loads in vitro and in vivo, while preventing the selection of resistant mutants. However, the combination may not fully prevent the emergence of fosfomycin-resistant mutants in colistin-resistant strains.
Background: Alternative treatments are needed against NDM-1-producing Escherichia coli. Colistin (COL) and fosfomycin (FOS) often remain active in vitro but selection of resistant mutants is frequent if used separately. We determined whether the combination of colistin and fosfomycin may be useful to treat infections with NDM-1-producing E. coli with varying levels of resistance. Methods: Isogenic derivatives of E. coli CFT073 with bla(NDM-1) and variable levels of resistance to colistin and fosfomycin (CFT073-NDM1, CFT073-NDM1-COL and CFT073-NDM1-FOS, respectively) were used. The combination (colistin ! fosfomycin) was tested in vitro and in a fatal peritonitis murine model. Mortality and bacterial loads were determined and resistant mutants detected. Results: Colistin MICs were 0.5, 16 and 0.5 mg/L and fosfomycin MICs were 1, 1 and 32 mg/L against CFT073NDM1, CFT073-NDM1-COL and CFT073-NDM1-FOS, respectively. In time-kill curves, combining colistin with fosfomycin was synergistic and bactericidal against CFT073-NDM1 and CFT073-NDM1-FOS, with concentrations of 4% MIC (for both drugs), but not against CFT073-NDM1-COL (concentrations of colistin = 0.5% MIC), due to regrowth with fosfomycin-resistant mutants. Mice died less and bacterial counts were lower in spleen with the combination compared with monotherapy against all strains; the combination prevented selection of resistant mutants except for CFT073-NDM1-COL where fosfomycin-resistant mutants were found in all mice. Conclusions: Combining colistin and fosfomycin was beneficial in vitro and in vivo against NDM-1-producing E. coli, even with strains less susceptible to colistin and fosfomycin. However, the combination failed to prevent the emergence of fosfomycin-resistant mutants against colistin-resistant strains. Combining colistin and fosfomycin constitutes an alternative for treatment of NDM-1 E. coli, except against colistin-resistant strains.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据